122846

: There are high-quality papers regarding the efficacy of AL2846 capsules , a multi-target tyrosine kinase inhibitor, in treating advanced solid tumors. Recent results published in the Annals of Oncology highlight its safety profile in clinical trials.

: A prospective clinical registry for evaluating exanthematous infections is registered under this ID at ClinicalTrials.gov . Reference & Industry Standards 122846